SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.40    -0.41 (-8.52%)
Bid:
4.40
Ask:
4.50
Spread: 0.10 (2.273%)
Market Cap: £27.45m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Immupharma News

IN BRIEF: ImmuPharma US partner gets Type C meeting with US FDA
7 Jul 2022

IN BRIEF: ImmuPharma US partner gets Type C meeting with US FDA

ImmuPharma PLC - specialist drug discovery and development company - Says Avion Pharmaceuticals, its US partner for its Lupuzor lupus treatment, recei...

IN BRIEF: ImmuPharma shares fall as annual loss widens
25 May 2022

IN BRIEF: ImmuPharma shares fall as annual loss widens

ImmuPharma PLC - specialist drug discovery and development company - Widens its pretax loss to GBP8.9 million in 2021 from GBP7.2 million loss the pre...

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well
6 May 2022

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

ImmuPharma making final preparations for Lupuzor phase 3 trial
4 May 2022

ImmuPharma making final preparations for Lupuzor phase 3 trial

(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Wednesday that final preparations were now underway to progres...

ImmuPharma surges on success in latest trial of lupus treatment
13 Apr 2022

ImmuPharma surges on success in latest trial of lupus treatment

(Sharecast News) - Specialist drug discovery and development company ImmuPharma reported positive data from its 'Lupuzor' pharmacokinetic study on Wed...

IN BRIEF: Immupharma shares soar on positive data from lupus study
13 Apr 2022

IN BRIEF: Immupharma shares soar on positive data from lupus study

Immupharma PLC - London-based drug discovery and development company - Says its Lupuzor/P140 pharmacokinetic study, required by the US Food & Drug Adm...

AIM WINNERS & LOSERS: ImmuPharma hits milestone; Shearwater contract
13 Apr 2022

AIM WINNERS & LOSERS: ImmuPharma hits milestone; Shearwater contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.